Diltiazem Hydrochloride Capsules Recalled Due to Failed Dissolution Specifications
Glenmark Pharmaceuticals is recalling 6,528 bottles of Diltiazem Hydrochloride Extended-Release Capsules nationwide because dissolution testing found the product does not meet specifications. The FDA has classified this as a Class II recall.
- Product
- DILTIAZEM HYDROCHLORIDE — DILTIAZEM HYDROCHLORIDE (DILTIAZEM HYDROCHLORIDE)
- Category
- Drug
- Distribution
- Distributed nationwide